SC
AXLA

Shay Capital’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Shay Capital’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,000
Closed -$16.4K – 540
2022
Q4 		$16.4K Buy
+2,000
New +$51.8K 0.01% 260

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

Shay Capital's AXLA Position: Q1 2023 in Review

Shay Capital sold out of Axcella Health Inc. Common Stock (AXLA) in Q1 2023, closing a stake of 2,000 shares — an estimated $16.4K sold.

Shay Capital first reported a position in AXLA in Q4 2022 and held it in 1 quarter. The position peaked at $16.4K in Q4 2022. 29 funds tracked by Wall St. Rank hold AXLA as of Q1 2023.

  • Shay Capital reported no remaining Axcella Health Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Shay Capital sold 2,000 Axcella Health Inc. Common Stock shares in Q1 2023, an estimated $16.4K.
  • Shay Capital first reported a position in Axcella Health Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Shay Capital's Axcella Health Inc. Common Stock position peaked at $16.4K in Q4 2022.
  • 29 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q1 2023.

Based on Shay Capital's 13F filing for Q1 2023, filed 15 May 2023.